Metraipolis › archive › dc_bcb6c874e017

Efficacy of cadonilimab in combination with nimotuzumab and AG regimen in TMB-H/KRAS wild-type advanced pancreatic cancer: a case report — Europe PMC PMID:41098733

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41098733
DOI
10.3389/fimmu.2025.1652827
License (as archived)
solo-consultazione
Archived
2026-11-09T17:05:32.542Z
SHA-256 of the archived text
bc916600a9b81ee15f202fa0a198e382cd3b75595b462f3f968f4088c81a8a7a
Stable URL of this page
https://metraipolis.com/documento/dc_bcb6c874e017

How to cite

Efficacy of cadonilimab in combination with nimotuzumab and AG regimen in TMB-H/KRAS wild-type advanced pancreatic cancer: a case report — Europe PMC PMID:41098733 — Europe PMC (en), https://europepmc.org/article/MED/41098733 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcb6c874e017 (Metraipolis archive dc_bcb6c874e017, sha256 bc916600a9b81ee15f202fa0a198e382cd3b75595b462f3f968f4088c81a8a7a)
BibTeX
@misc{dcbcb6c874e017,
  title = {Efficacy of cadonilimab in combination with nimotuzumab and AG regimen in TMB-H/KRAS wild-type advanced pancreatic cancer: a case report — Europe PMC PMID:41098733},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41098733},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcb6c874e017; sha256 bc916600a9b81ee15f202fa0a198e382cd3b75595b462f3f968f4088c81a8a7a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41098733. Agents can read the archived copy with the MCP tool read_document.